| 20230 |
11-trans Leukotriene C4
|
|
74841-69-3 |
>97%
|
|
|
|
69.417900552486
|
11-trans-leukotriene-c4
|
11-trans LTC4
|
11-trans-LTC4 leukotrienes isomers |
69.417900552486
|
| 20330 |
11-trans Leukotriene D4
|
|
79768-40-4 |
>97%
|
|
|
|
47.830902394106
|
11-trans-leukotriene-d4
|
11-trans LTD4
|
11-trans-LTD4 isomers leukotrienes |
47.830902394106
|
| 20430 |
11-trans Leukotriene E4
|
|
75715-88-7 |
>97%
|
|
|
|
48.803204419890
|
11-trans-leukotriene-e4
|
11-trans LTE4
|
11-trans-LTE4 isomers leukotrienes |
48.803204419890
|
| 62210 |
1,2-Didecanoyl-sn-glycerol
|
|
60514-49-0 |
≥95%
|
|
|
|
3.321436464088
|
1-2-didecanoyl-sn-glycerol
|
|
DAG diacylglyceride 1,2-bis-(O-decanoyl)-sn-glycerol analogs |
3.321436464088
|
| 20134 |
12-epi Leukotriene B3
|
|
- |
>97%
|
|
|
|
1.657237569061
|
12-epi-leukotriene-b3
|
12-epi LTB3
|
isomers 12-epi-LTB3 12(S)-LTB3 leukotrienes 12S-LTB3 |
1.657237569061
|
| 20135 |
12-epi Leukotriene B4
|
|
83709-73-3 |
>97%
|
|
|
|
52.168287292818
|
12-epi-leukotriene-b4
|
12-epi LTB4
|
isomers 12-epi-LTB4 12(S)-LTB4 leukotrienes 12S-LTB4 |
52.168287292818
|
| 320135 |
12-epi Leukotriene B4-d4
|
|
- |
≥99% deuterated forms (d1-d4)
|
|
|
|
94.801712707182
|
12-epi-leukotriene-b4-d4
|
12-epi LTB4-d4
|
12-epi-LTB4-d4 12(S)-LTB4-d4 12(S)LTB4-d4 12S-LTB4-d4 leukotrienes mass spectrometry GC/MS LC/MS GC-MS LC-MS internal standards deuterated deuterium isotopes |
94.801712707182
|
| 20140 |
12-oxo Leukotriene B4
|
|
136696-10-1 |
≥95%
|
|
|
2009-03-06
|
26.550049723756
|
12-oxo-leukotriene-b4
|
12-keto LTB4; 12-oxo LTB4
|
LTB4 metabolism PMNL neutrophils inflammation chemotaxis chemokinesis 12-keto leukotriene B4 12-keto-leukotriene B4 |
26.550049723756
|
| 44570 |
12(S)-HpETE
|
|
71774-10-2 |
≥98%
|
|
|
|
15.973491712707
|
12-s-hpete
|
|
12-LOs 12-HpETEs 12S-HpETEs hydroperoxides 12-lipoxygenases 12(S)-HpETEs monohydroperoxy fatty arachidonic acids polyunsaturated |
15.973491712707
|
| 10007258 |
12(S)-HpETE Lipid Maps MS Standard
|
|
71774-10-2 |
≥98%
|
|
|
2009-02-02
|
13.373845303867
|
12-s-hpete-lipid-maps-ms-standard
|
|
12-LOs 12-HpETEs 12S-HpETEs hydroperoxides 12-lipoxygenases 12(S)-HpETEs monohydroperoxy fatty arachidonic acids polyunsaturated MS mass spectrometry standard |
13.373845303867
|
| 20150 |
14,15-dehydro Leukotriene B4
|
|
114616-11-4 |
>97%
|
|
|
2008-06-02
|
41.183911602210
|
14-15-dehydro-leukotriene-b4
|
14,15-dehydro LTB4
|
leukotrienes inflammation leukocytes antagonist LTB4 5-LO 5LO allergy asthma LTs inhibits inhibitors inhibition |
41.183911602210
|
| 10011360 |
14,15-Leukotriene C4
|
|
75290-60-7 |
>95%
|
|
|
2008-05-23
|
42.751123388581
|
14-15-leukotriene-c4
|
EXC4; Eoxin C4; 14,15-LTC4
|
leukotrienes inflammation leukocytes 5-LO 15-LO 12-LO 5LO 15LO 12LO epoxytrienes asthma allergy pulmonary diseases eoxin inflammatory |
42.751123388581
|
| 10006748 |
14,15-Leukotriene C4 EIA Kit
|
|
- |
|
|
|
2006-03-21
|
103.999033149171
|
14-15-leukotriene-c4-eia-kit
|
14,15-LTC4 EIA Kit; 14,15-Leukotriene C4 ELISA Kit
|
solid plates eias assays 9000291 |
103.999033149171
|
| 10011362 |
14,15-Leukotriene E4
|
|
1000852-57-2 |
≥97%
|
|
|
2008-11-15
|
52.545722178374
|
14-15-leukotriene-e4
|
14,15-LTE4; EXE4; Eoxin E4
|
leukotrienes inflammations leukocytes 5-LO 5LO 15LO 15-LO 12-LO 12LO epoxytrienes asthma allergy pulmonary disease eoxin cyslts cysteinyl leukotrienes |
52.545722178374
|
| 34720 |
15(S)-HETE
|
|
54845-95-3 |
≥98%
|
|
|
|
36.312494080505
|
15-s-hete
|
|
soybean 15-LOs asthma airway 15-lipoxygenases monohydroxy fatty acids 15S-HETES 15-HETES arachidonic 15(S)-HETEs 15(S)HETEs potato polyunsaturated 15HETEs |
36.312494080505
|
| 334720 |
15(S)-HETE-d8
|
|
84807-87-4 |
≥99% deuterated forms (d1-d8)
|
|
|
|
33.119594843463
|
15-s-hete-d8
|
|
GC/MS deuterium isotopes 15-HETE-d8 standards 15S-HETE-d8 15(S)HETE-d8 deuterated GC-MS LC/MS LC-MS 15-HETEs 15(S)-HETEs 15S-HETEs 15(S)HETEs hydroxy fatty acids mass spectrometry 15HETE |
33.119594843463
|
| 534721 |
15(S)-HETE EIA Kit
|
|
- |
|
|
|
|
73.321731123388
|
15-s-hete-eia-kit
|
15(S)-HETE ELISA Kit
|
solid plates 15(S)-HETEs 15S-HETEs measures kits eias enzyme immunoassays ELISAs 15(S)HETEs 15HETEs assays |
73.321731123388
|
| 10007251 |
15(S)-HETE Lipid Maps MS Standard
|
|
54845-95-3 |
≥98%
|
|
|
2009-02-17
|
16.312885677858
|
15-s-hete-lipid-maps-ms-standard
|
|
soybean 15-LOs asthma airway 15-lipoxygenases monohydroxy fatty acids 15S-HETES 15-HETES arachidonic 15(S)-HETEs 15(S)HETEs potato polyunsaturated MS mass spectrometry standards 15HETE |
16.312885677858
|
| 44720 |
15(S)-HpETE
|
|
70981-96-3 |
≥98%
|
|
|
|
17.295543278085
|
15-s-hpete
|
|
15-LOs 15-HpETEs 15S-HpETEs hydroperoxides 15(S)-HpETEs 15(S)HPETEs 15-lipoxygenases monohydroperoxy fatty arachidonic acids polyunsaturated |
17.295543278085
|
| 10007259 |
15(S)-HpETE Lipid Maps MS Standard
|
|
70981-96-3 |
>98%
|
|
|
2009-02-10
|
9.112486187845
|
15-s-hpete-lipid-maps-ms-standard
|
|
15-LOs 15-HpETEs 15S-HpETEs hydroperoxides 15(S)-HpETEs 15(S)HPETEs 15-lipoxygenases monohydroperoxy fatty arachidonic acids polyunsaturated MS mass spectrometry standards |
9.112486187845
|
| 20170 |
18-carboxy dinor Leukotriene B4
|
|
102674-12-4 |
≥97%
|
|
|
2009-02-24
|
260.950419889502
|
18-carboxy-dinor-leukotriene-b4
|
18-carboxy dinor LTB4
|
LTs leukotrienes metabolism β-oxidation β oxidation liver LTBs |
260.950419889502
|
| 20180 |
20-carboxy Leukotriene B4
|
|
80434-82-8 |
>97%
|
|
|
|
62.911841620626
|
20-carboxy-leukotriene-b4
|
20-carboxy LTB4
|
leukotrienes metabolites 20-carboxy-LTB4 |
62.911841620626
|
| 20190 |
20-hydroxy Leukotriene B4
|
|
79516-82-8 |
>97%
|
|
|
|
64.968305709023
|
20-hydroxy-leukotriene-b4
|
20-hydroxy LTB4
|
leukotrienes metabolites 20-hydroxy-LTB4 20-OH-LTB4 hydroxylated |
64.968305709023
|
| 20195 |
20-trifluoro Leukotriene B4
|
|
115178-97-7 |
>97%
|
|
|
|
175.757513812155
|
20-trifluoro-leukotriene-b4
|
20-trifluoro LTB4
|
20-CF3-LTB4 leukotrienes 20-trifluoro-LTB4 metabolites |
175.757513812155
|
| 42210 |
5(S)-HpEPE
|
|
- |
≥98%
|
|
|
|
13.768545119706
|
5-s-hpepe
|
|
EPA hydroperoxides 5-HpEPEs 5S-HpEPEs 5-LOs eicosapentaenoic fatty acids hydroperoxy 5-lipoxygenases 5(S)-HpEPEs 5(S)HpEPEs |
13.768545119706
|
| 44230 |
5(S)-HpETE
|
|
71774-08-8 |
≥98%
|
|
|
|
21.915064456721
|
5-s-hpete
|
|
5-LOs 5-HpETEs hydroperoxides 5S-HpETEs 5(S)HpETEs hydroperoxy 5-lipoxygenases 5(S)-HpETEs arachidonic fatty acids leukotrienes |
21.915064456721
|
| 10007257 |
5(S)-HpETE Lipid Maps MS Standard
|
|
71774-08-8 |
≥98%
|
|
|
2009-02-04
|
7.518397790055
|
5-s-hpete-lipid-maps-ms-standard
|
|
5-LOs 5-HpETEs hydroperoxides 5S-HpETEs 5(S)HpETEs hydroperoxy 5-lipoxygenases 5(S)-HpETEs arachidonic fatty acids leukotrienes MS mass spectrometry standards |
7.518397790055
|
| 35265 |
6-trans-12-epi Leukotriene B4
|
|
71548-19-1 |
≥97%
|
|
|
|
47.141933701657
|
6-trans-12-epi-leukotriene-b4
|
5(S),12(S)-DiHETE; 6-trans-12-epi LTB4
|
leukotrienes 6-trans-12-epi-LTB4 isomers LTA4 hydrolysis LTs |
47.141933701657
|
| 10007256 |
6-trans-12-epi Leukotriene B4 Lipid Maps MS Standard
|
|
71548-19-1 |
≥97%
|
|
|
2009-01-28
|
37.374486187845
|
6-trans-12-epi-leukotriene-b4-lipid-maps-ms-standard
|
6-trans-12-epi LTB4; 5(S),12(S)-DiHETE
|
leukotrienes 6-trans-12-epi-LTB4 isomers LTA4 hydrolysis LTs MS mass spectrometry standards |
37.374486187845
|
| 35250 |
6-trans Leukotriene B4
|
|
71652-82-9 |
≥97%
|
|
|
|
61.642990331492
|
6-trans-leukotriene-b4
|
All trans LTB4; 5(S),12(R)-DiHETE; 6-trans LTB4
|
leukotrienes 6-trans-LTB4 LTA4 hydrolysis |
61.642990331492
|
| 10007254 |
6-trans Leukotriene B4 Lipid Maps MS Standard
|
|
71652-82-9 |
≥97%
|
|
|
2009-02-17
|
68.115003946330
|
6-trans-leukotriene-b4-lipid-maps-ms-standard
|
All trans LTB4; 6-trans LTB4; 5(S),12(R)-DiHETE
|
leukotrienes 6-trans-LTB4 LTA4 hydrolysis MS mass spectrometry standards |
68.115003946330
|
| 10008640 |
Asthma Treatment Standard Set
|
|
- |
|
|
|
2006-07-13
|
12.548692449355
|
asthma-treatment-standard-set
|
|
CysLT1 receptors cysteinyl leukotrienes asthma allergy antagonists LTC4 LTD4 hypersensitivity oral peptidyl LTRA bronchoconstriction montelukast pranlukast zafirlukast zileuton 10006967 packs |
12.548692449355
|
| 120112 |
BLT1 Receptor Blocking Peptide
|
|
- |
~30%
|
|
|
|
2.192541436464
|
blt1-receptor-blocking-peptide
|
Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1
|
BLT-1 receptors leukotrienes controls peptides flow cytometry FACS ICC immunocytochemistry antibodies |
2.192541436464
|
| 120111 |
BLT1 Receptor Monoclonal Antibody (Clone 7B1)
|
|
- |
|
|
|
|
27.399629044988
|
blt1-receptor-monoclonal-antibody-clone-7b1
|
Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1
|
LTB4R1 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera flow cytometry immunocytochemistry icc immunohistochemistry ihc atherosclerosis FC |
27.399629044988
|
| 120114 |
BLT1 Receptor Polyclonal Antibody
|
|
- |
|
|
|
|
6.180524861878
|
blt1-receptor-polyclonal-antibody
|
Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1
|
LTB4R1 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera flow cytometry immunocytochemistry icc WB western blots blotting immunohistochemistry ihc atherosclerosis immunoblotting FC |
6.180524861878
|
| 100019 |
BLT1 Receptor Polyclonal Antiserum
|
|
- |
|
|
|
|
2.877071823204
|
blt1-receptor-polyclonal-antiserum
|
Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1
|
C-terminus C-terminal intracellular plasma membranes whole cells LTB4R1 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera flow cytometry immunocytochemistry icc WB western blots blotting immunohistochemistry ihc chronic pancreatitis pancreatic cancers pancreas atherosclerosis immunoblotting FC |
2.877071823204
|
| 320124 |
BLT2 Receptor Blocking Peptide
|
|
- |
|
|
|
|
6.357834254143
|
blt2-receptor-blocking-peptide
|
Leukotriene B4 Receptor 2; LTB4 Receptor 2; BLTR2
|
peptides controls receptors leukotrienes immunofluorescence flow cytometry FACs WB western blotting blots antibodies |
6.357834254143
|
| 120124 |
BLT2 Receptor Polyclonal Antibody
|
|
- |
|
|
|
|
122.215911602209
|
blt2-receptor-polyclonal-antibody
|
Leukotriene B4 Receptor 2; LTB4 Receptor 2; BLTR2
|
LTB4R2 LTB4-R2 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera western blots blotting WB atherosclerosis immunoblotting |
122.215911602209
|
| 10804 |
CAY10649
Exclusive
|
|
1272519-89-7 |
≥98%
|
|
✓ |
2011-04-04
|
16.559235727440
|
cay10649
|
|
5-LO leukotrienes 5-lipoxygenases inhibitors inflammation smooth muscle contraction inhibition inhibited PMNL inflammatory |
16.559235727440
|
| 10743 |
CAY10650
Exclusive
|
|
1233706-88-1 |
≥98%
|
|
✓ |
2011-06-14
|
12.111933701657
|
cay10650
|
|
cPLA2α cPLA2 inhibitors inflammation anti-inflammatory dermatitis metabolite phospholipase cytosolic prostaglandins PGs leukotrienes synthesis 10662 CAY-10650 CAY10641 CAY-10641 |
12.111933701657
|
| 320500 |
CysLT1 Receptor Blocking Peptide
|
|
- |
|
|
|
|
38.366519337016
|
cyslt1-receptor-blocking-peptide
|
Cysteinyl Leukotriene Receptor 1
|
peptides controls receptors cys-leukotrienes cys-LT1 immunofluorescence flow cytometry cysteinyl-leukotrienes cysteinyl-LT1 cysteinyl-LTs cys-LTs antibodies |
38.366519337016
|
| 120500 |
CysLT1 Receptor Polyclonal Antibody
|
|
- |
|
|
|
|
71.259303867403
|
cyslt1-receptor-polyclonal-antibody
|
Cysteinyl Leukotriene Receptor 1
|
cysteinyl-leukotrienes receptors antibodies LTC4 LTD4 LTE4 Cys-LT1 human flow cytometry asthma peptido-leukotrienes FACS antisera immunochemistry icc immunohistory ihc antiserum wb western blotting blots atherosclerosis immunoblotting immunocytochemistry immunohistochemistry FC |
71.259303867403
|
| 120550 |
CysLT2 Receptor (C-Term) Polyclonal Antibody
|
|
- |
|
|
|
|
4.465534069981
|
cyslt2-receptor-c-term-polyclonal-antibody
|
Cysteinyl-Leukotriene Receptor 2
|
cysteinyl-leukotrienes receptors antibodies LTC4 LTD4 LTE4 Cys-LT2 human flow cytometry asthma peptido-leukotrienes wb western blots blotting leukotrienes CysLTs cys-LTs antisera antiserum immunohistochemistry ihc atherosclerosis FC immunoblotting |
4.465534069981
|
| 320560 |
CysLT2 Receptor (N-Term) Blocking Peptide
|
|
- |
|
|
|
|
6.133112338858
|
cyslt2-receptor-n-term-blocking-peptide
|
Cysteinyl Leukotriene Receptor 2 (N-Term)
|
peptides controls receptors cys-leukotrienes cys-LT2 n-terminal n-terminus immunofluorescence flow cytometry nt western blots blotting wb cysteinyl-leukotrienes cysteinyl-LT2 cysteinyl-LTs cys-LTs antibodies |
6.133112338858
|
| 120560 |
CysLT2 Receptor (N-Term) Polyclonal Antibody
|
|
- |
|
|
|
|
6.745690607735
|
cyslt2-receptor-n-term-polyclonal-antibody
|
Cysteinyl-Leukotriene Receptor 2
|
cysteinyl-leukotrienes receptors antibodies LTC4 LTD4 LTE4 Cys-LT2 human flow cytometry asthma peptido-leukotrienes western blots blotting antisera antiserum nt wb icc immuncytochemistry ihc atherosclerosis immunohistochemistry facs flow cytometry immunoblotting FC |
6.745690607735
|
| 10009291 |
Cysteinyl Leukotriene Express EIA Kit
|
|
- |
|
|
|
2008-08-11
|
254.400657960824
|
cysteinyl-leukotriene-express-eia-kit
|
CysLT Express ELISA Kit
|
solid plates leukotrienes CysLTs acute inflammatory mediators arachidonic acids leukocytes 5-LO lipoxygenases bone marrow cells eosinophils mast macrophages LTA4 LTC4 LTD4 LTE4 human lungs mediators asthma hypersensitivity bronchoconstriction microvascular permeability vasoconstrictors coronary arteries competitive assays kits quantification urine culture media sample matrix matrices enzymes immuno ELISAs |
254.400657960824
|
| 20001 |
Cysteinyl Leukotriene HPLC Mixture I
|
|
- |
≥98% for each compound
|
|
|
|
14.563188634569
|
cysteinyl-leukotriene-hplc-mixture-i
|
CysLT HPLC Mixture I
|
peptido-Leukotrienes LTF4 LTC4 LTD4 N-acetyl-LTE4 cysteinyl leukotrienes chromatography peptido-LTs cys-LTs cysteinyl-LTs |
14.563188634569
|
| 20002 |
Cysteinyl Leukotriene HPLC Mixture II
|
|
- |
≥98% for each compound
|
|
|
|
15.300368324125
|
cysteinyl-leukotriene-hplc-mixture-ii
|
CysLT HPLC Mixture II
|
peptido-leukotrienes LTD4 LTE4 LTF4 N-acetyl-LTC4 PGB2 cysteinyl leukotrienes chromatography cysteinyl-LTs cys-LTs peptido-LTs |
15.300368324125
|
| 20009 |
Leukotriene A3 methyl ester
|
|
83851-38-1 |
>97%
|
|
|
|
5.315288082083
|
leukotriene-a3-methyl-ester
|
LTA3 methyl ester
|
leukotrienes esters LTA3-OMe |
5.315288082083
|
| 10006197 |
Leukotriene A4-d5 methyl ester
Exclusive
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
✓ |
2008-10-27
|
32.179706794610
|
leukotriene-a4-d5-methyl-ester
|
LTA4-d5 methyl ester
|
leukotrienes asthma esters LTA4-OMe GC/MS LC/MS GC-MS LC-MS mass spectrometry deuterium isotopes LTA4-d5 leukotrienes esters deuterated internal standards |
32.179706794610
|
| 10007817 |
Leukotriene A4 Hydrolase (human recombinant)
|
|
- |
≥90%
|
|
|
2005-12-14
|
275.808100344092
|
leukotriene-a4-hydrolase-human-recombinant
|
LTA4H
|
leukotrienes bifunctional zinc metalloenzymes converts LTB4 neutrophils chemoattractants hydrolases activity anion-dependent aminopeptidases drugs leukocytes infiltration inflammation E. coli epoxides atherosclerosis active |
275.808100344092
|
| 160250 |
Leukotriene A4 Hydrolase Polyclonal Antibody
|
|
- |
|
|
|
|
187.400510726632
|
leukotriene-a4-hydrolase-polyclonal-antibody
|
LTA4 Hydrolase
|
LTA4 leukotrienes LTB4 5-lipoxygenases antibodies 5-LOS western blots blotting WB antisera antiserum hydrolases immunoblotting |
187.400510726632
|
| 20010 |
Leukotriene A4 methyl ester
|
|
73466-12-3 |
>97%
|
|
|
|
181.971189680001
|
leukotriene-a4-methyl-ester
|
LTA4 methyl ester
|
leukotrienes asthma esters LTA4-OMe |
181.971189680001
|
| 20109 |
Leukotriene B3
|
|
88099-35-8 |
>97%
|
|
|
|
59.848011049724
|
leukotriene-b3
|
LTB3
|
leukotrienes LTB3 inflammation |
59.848011049724
|
| 20110 |
Leukotriene B4
|
|
71160-24-2 |
≥97%
|
|
|
|
180.943799155021
|
leukotriene-b4
|
LTB4
|
leukotrienes LTB4 inflammation chemotaxis atherosclerosis |
180.943799155021
|
| 20114 |
Leukotriene B4-3-aminopropylamide
|
|
89596-43-0 |
≥95%
|
|
|
2009-03-05
|
429.324088397790
|
leukotriene-b4-3-aminopropylamide
|
LTB4-3-aminopropylamide
|
LTB LTB4 BLTs BLT1 BLT2 inflammation immunology |
429.324088397790
|
| 320110 |
Leukotriene B4-d4
|
|
- |
≥99% deuterated forms (d1-d4)
|
|
|
|
143.486187845304
|
leukotriene-b4-d4
|
LTB4-d4
|
GC/MS LTB4-d4 deuterium internal standards isotopes leukotrienes GC-MS mass spectrometry LC/MS LC-MS deuterated spectroscopy atherosclerosis mass spectrometry |
143.486187845304
|
| 20115 |
Leukotriene B4 dimethyl amide
|
|
83024-92-4 |
>97%
|
|
|
|
90.676325966851
|
leukotriene-b4-dimethyl-amide
|
LTB4 dimethyl amide
|
leukotrienes LTB4 antagonists analogs BLTR1 receptors amides |
90.676325966851
|
| 520111 |
Leukotriene B4 EIA Kit
|
|
- |
|
|
|
|
1106.047323511356
|
leukotriene-b4-eia-kit
|
Leukotriene B4 ELISA Kit
|
solid plates neutrophils 5-LOs 5-lipoxygenases LTB4 measures kits atherosclerosis eias enzyme immunoassays ELISAs leukotrienes assays |
1106.047323511356
|
| 20112 |
Leukotriene B4 Ethanolamide
|
|
- |
>97%
|
|
|
|
33.184814522494
|
leukotriene-b4-ethanolamide
|
LTB4-EA
|
BLTR2 receptors leukotrienes LTB4 ethanolamides cannabinoids anandamides ligands BLT2 neuroscience ethanolamines |
33.184814522494
|
| 10007240 |
Leukotriene B4 Lipid Maps MS Standard
|
|
71160-24-2 |
≥97%
|
|
|
2009-01-14
|
29.751524861878
|
leukotriene-b4-lipid-maps-ms-standard
|
LTB4
|
leukotrienes LTB4 inflammation chemotaxis atherosclerosis LTs MS mass spectrometry standards |
29.751524861878
|
| 20210 |
Leukotriene C4
|
|
72025-60-6 |
≥97%
|
|
|
|
146.582855481245
|
leukotriene-c4
|
LTC4
|
cysteinyl-leukotrienes LTC4 asthma SRS-A slow-reacting substance anaphylaxis allergy peptido-leukotrienes cysteinyl-LTs peptido-LTs cys-LTs |
146.582855481245
|
| 10006198 |
Leukotriene C4-d5
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
|
2007-04-11
|
154.699889502763
|
leukotriene-c4-d5
|
LTC4-d5
|
cysteinyl-leukotrienes LTC4 asthma SRS-A slow-reacting substance anaphylaxis allergy peptido-leukotrienes cysteinyl-LTs peptido-LTs cys-LTs GC/MS deuterium isotopes LTC4-d5 internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry |
154.699889502763
|
| 520211 |
Leukotriene C4 EIA Kit
|
|
- |
|
|
|
|
258.024521886953
|
leukotriene-c4-eia-kit
|
Leukotriene C4 ELISA Kit
|
solid plates kitrecommendation:cyslt 5-Los 5-lipoxygenases allergy cysteinyl-leukotrienes cys-LTs neutrophils peptido-leukotrienes LTC4 measures kits eias enzyme immunoassays ELISAs asthma cysteinyl-LTs peptido-LTs assays |
258.024521886953
|
| 10007241 |
Leukotriene C4 Lipid Maps MS Standard
|
|
72025-60-6 |
>97%
|
|
|
2009-01-07
|
45.879165131982
|
leukotriene-c4-lipid-maps-ms-standard
|
LTC4
|
cysteinyl-leukotrienes LTC4 asthma SRS-A slow-reacting substance anaphylaxis allergy peptido-leukotrienes cysteinyl-LTs peptido-LTs cys-LTs MS mass spectrometry standards asthma cyslts |
45.879165131982
|
| 10007164 |
Leukotriene C4 methyl ester
|
|
73958-10-8 |
>97%
|
|
|
2005-11-23
|
56.971809392265
|
leukotriene-c4-methyl-ester
|
LTC4 methyl ester
|
peptido-leukotrienes LTE4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs cysLTs peptido-LTs cys-LTs cysteinyl-leukotrienes fatty acids backbone dipeptidases plasma lipids soluble |
56.971809392265
|
| 20310 |
Leukotriene D4
|
|
73836-78-9 |
>97%
|
|
|
|
162.167262124002
|
leukotriene-d4
|
LTD4
|
cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes LTD4 asthma SRS-A bronchoconstriction peptido-leukotrienes slow-reacting substance anaphylaxis allergy metabolites |
162.167262124002
|
| 10006199 |
Leukotriene D4-d5
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
|
2008-04-23
|
52.451625887924
|
leukotriene-d4-d5
|
LTD4-d5
|
peptido-leukotrienes LTD4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes deuterated deuterium cysLTs GC/MS GC-MS LC/MS LC-MS mass spectrometry |
52.451625887924
|
| 10007165 |
Leukotriene D4 methyl ester
|
|
- |
>97%
|
|
|
2005-09-07
|
41.494419889502
|
leukotriene-d4-methyl-ester
|
|
cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes asthma SRS-A bronchoconstriction peptido-leukotrienes slow-reacting substance anaphylaxis allergy metabolites acute hypersensitivity vascular permeability |
41.494419889502
|
| 20410 |
Leukotriene E4
|
|
75715-89-8 |
>97%
|
|
|
|
91.881151721207
|
leukotriene-e4
|
LTE4
|
peptido-leukotrienes LTE4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes |
91.881151721207
|
| 10007858 |
Leukotriene E4-d5
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
|
2008-04-08
|
110.897298956415
|
leukotriene-e4-d5
|
LTE4-D5
|
peptido-leukotrienes LTE4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes deuterated deuterium cysLTs GC/MS GC-MS LC/MS LC-MS mass spectrometry |
110.897298956415
|
| 520411 |
Leukotriene E4 EIA Kit
|
|
- |
|
|
|
|
178.613555643251
|
leukotriene-e4-eia-kit
|
Leukotriene E4 ELISA Kit
|
solid plates kitrecommendation:cyslt allergy cys-LTs cysteinyl-leukotrienes atherosclerosis neutrophils LTE4 measures kits eias enzyme immunoassays ELISAs asthma cysteinyl-LTs peptido-LTs peptido-leukotrienes assays |
178.613555643251
|
| 10007242 |
Leukotriene E4 Lipid Maps MS Standard
|
|
75715-89-8 |
>97%
|
|
|
2009-01-06
|
56.993003157064
|
leukotriene-e4-lipid-maps-ms-standard
|
LTE4
|
peptido-leukotrienes LTE4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes LTs MS mass spectrometry standards |
56.993003157064
|
| 10007166 |
Leukotriene E4 methyl ester
|
|
- |
>97%
|
|
|
2005-10-25
|
41.979657458563
|
leukotriene-e4-methyl-ester
|
|
peptido-leukotrienes LTD4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes fatty acids backbone dipeptidases plasma lipids soluble |
41.979657458563
|
| 20520 |
Leukotriene F4
|
|
83851-42-7 |
>97%
|
|
|
|
94.883278084714
|
leukotriene-f4
|
LTF4
|
LTF4 leukotrienes asthma allgery cysteinyl-leukotrienes peptido-leukotrienes cysteinyl-LTs peptido-LTs cys-LTs |
94.883278084714
|
| 10007577 |
Luminex® Cysteinyl Leukotriene Kit
|
|
- |
|
|
|
2006-12-01
|
49.649348066298
|
luminex-cysteinyl-leukotriene-kit
|
|
cys-LTs LTC4 LTD4 LTE4 measures kits asthma peptido-lts peptido-leukotrienes cysteinyl-leukotrienes allergy cysteinyl-LTs luminex xMAP beads kits assays |
49.649348066298
|
| 500260 |
Luminex® Leukotriene B4 Kit
|
|
- |
|
|
|
2008-11-12
|
61.059580110497
|
luminex-leukotriene-b4-kit
|
Luminex® LTB4 Kit
|
leukotrienes arachidonic acids 5-lipoxygenases LTA4 hydrolases mediator inflammation leukocytes aggregation stimulation stimulates fluxes lysosomes lysosomal kits enzymes release superoxides anions production chemotaxis chemokinesis subnanomolar human neutrophils degranulation plasma hepatocytes 20-hydroxy 20-carboxy NADPH-dependent nicotinamides adenines dinucleotides phosphates CYP450 cytochromes b-oxidation .beta.-oxidation beta-oxidation w-end omega-end .omega.-end w-carboxy omega-carboxy .omega.-carboxy dinor tetranor urine culture media sample matrices EIAs ELISAs enzyme immunoassays assays |
61.059580110497
|
| 70710 |
LY171883
|
|
88107-10-2 |
>98%
|
|
|
|
12.531436464088
|
ly171883
|
|
LTD4 receptors antagonists leukotrienes ly-171883 cysLT1 |
12.531436464088
|
| 70715 |
LY255283
|
|
117690-79-6 |
>98%
|
|
|
2004-02-19
|
38.013121546961
|
ly255283
|
|
receptors antagonists inhibits inhibitors leukotrienes receptors BLT1 BLT2 chemotaxis LY-255283 LY 255283 |
38.013121546961
|
| 70230 |
LY83583
|
|
91300-60-6 |
>99%
|
|
|
2005-03-16
|
25.610662983425
|
ly83583
|
|
guanylate cyclase inhibitors leukotrienes cGMP sGC hypoxia |
25.610662983425
|
| 10029 |
MK 571
|
|
115104-28-4 |
>95%
|
|
|
2007-06-26
|
8.075000000000
|
mk-571
|
L 660711
|
LTD4 receptors antagonists leukotrienes mk571 mk-571 salts L660711 L-660711 cysLT1 bcatenin .beta.catenin |
8.075000000000
|
| 70720 |
MK 571 (sodium salt)
|
|
- |
≥95%
|
|
|
|
19.976988950276
|
mk-571-sodium-salt
|
L 660711
|
LTD4 receptors antagonists leukotrienes mk571 mk-571 salts L660711 L-660711 cysLT1 115104-28-4 |
19.976988950276
|
| 10008318 |
Montelukast (sodium salt)
|
|
151767-02-1 |
≥98%
|
|
|
2006-04-20
|
30.970520915548
|
montelukast-sodium-salt
|
Singulair®
|
cysteinyl-leukotrienes cysLT1 receptors antagonists LTC4 LTD4 mediators asthma hypersensitivity bronchoconstriction microvascular permeability vasoconstrictors coronary arteries protein-coupled GPCRs selective potent |
30.970520915548
|
| 20420 |
N-acetyl Leukotriene E4
|
|
80115-95-3 |
>97%
|
|
|
|
81.152541436465
|
n-acetyl-leukotriene-e4
|
N-acetyl LTE4
|
leukotrienes metabolites N-acetyl-LTE4 |
81.152541436465
|
| 13390 |
N-methyl Leukotriene C4
|
|
131391-65-6 |
>97%
|
|
|
2008-10-15
|
85.482108655616
|
n-methyl-leukotriene-c4
|
N-methyl LTC4
|
allergy allergies asthma anaphylaxis SRS-A cysteinyl leukotrienes LTs mimetics |
85.482108655616
|
| 10008319 |
Pranlukast
|
|
103177-37-3 |
≥98%
|
|
|
2006-05-23
|
15.214056827150
|
pranlukast
|
Ultair; ONO-1078
|
CysLT1 receptors cysteinyl leukotrienes asthma allergy antagonists LTC4 LTD4 hypersensitivity oral peptidyl LTRA bronchoconstriction |
15.214056827150
|
| 70600 |
REV 5901
|
|
101910-24-1 |
>98%
|
|
|
|
3.833245856353
|
rev-5901
|
|
leukotrienes receptors antagonists lipoxygenases inhibitors inhibits |
3.833245856353
|
| 70705 |
U-75302
|
|
119477-85-9 |
>98%
|
|
|
|
23.604364640884
|
u-75302
|
|
LTB4 receptors antagonists leukotrienes u75302 |
23.604364640884
|
| 10008282 |
Zafirlukast
|
|
107753-78-6 |
≥97%
|
|
|
2006-05-01
|
18.503117600631
|
zafirlukast
|
Accolate®
|
cysteinyl-leukotrienes cysLT1 receptors GPCRs protein-coupled antagonists asthma asthmatic allergies allergic rhinitis selective cysLTs cys-LTs cys-LT1 accolate™ |
18.503117600631
|
| 10006967 |
Zileuton
|
|
111406-87-2 |
>98%
|
|
|
2005-09-09
|
20.302014949626
|
zileuton
|
Zyflo®
|
cysteinyl-leukotrienes CysLTs LTC4 LTD4 LTE4 pathophysiology asthma arachidonic acids fatty 5-LO 5-lipoxygenases pathway inhibitors inhibition inhibits prevention treatment RBL-1 cells LTB4 production purified human peripheral blood PMNL |
20.302014949626
|